Hamostaseologie 1997; 17(03): 161-162
DOI: 10.1055/s-0038-1659983
Originalarbeiten/Original Articles
Schattauer GmbH

Antithrombotic Therapy for DVT/PE

Thomas M. Hyers
1   Saint Louis University School of Medicine St. Louis, U.S.A.
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Summary

Problems with unfractionated heparin as an antithrombotic have led to the development of new therapeutic agents. Of these, low molecular weight heparin shows great promise and has led to out-patient therapy of DVT/PE in selected patients. Oral anticoagulants remain the choice for long-term therapy. More cost-effective ways to give oral anticoagulants are needed.

 
  • LITERATURE

  • 1 Carson J.L, Kelley M.A, Duff A. et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-5.
  • 2 Hyers T.M, Hull R.D, Weg J.G. Antithrombotic therapy for venous thromboembolic disease. Chest 1995; 108: 335S-51S.
  • 3 Raschke R.A, Reilly B.M, Guidry J.R. et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram: a randomized controlled trial. Ann Intern Med 1993; 119: 874-81.
  • 4 Brill-Edwards P, Ginsberg J.S, Johnson M. et al. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993; 119: 104-9.
  • 5 Levine M, Gent M, Hirsh J. et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. N Engl J Med 1996; 334: 677-81.
  • 6 Koopman M.M.W, Prandoni P, Piovella F. et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home. N Engl J Med 1996; 334: 662-7.
  • 7 Prandoni P, Lensing A.W.A, Cogo A. et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
  • 8 White R.H, McCurdy S.A, von Marensdorff H. et al. Home prothrombin time monitoring after the initiation of warfarin therapy; a randomized prospective study. Ann Intern Med 1989; 111: 730-7.
  • 9 Bernardo A. Post Conference Session: Experience with patient self-management of oral anticoagulation. Anticoagulation Forum 1995; 321-5.